Periocular combined to different dosage Triamcinolone Acetonide intravitreal injection treatment macular edema associated with Retinal Vein Occlusion

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000997

Enrollment

Unknown

Registered

2010-06-25

Start date

2008-09-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema associated with Retinal Vein Occlusion

Interventions

A:intravitreal injection 4mg Triamcinolone Acetonide

B:intravitreal injection 8mg Triamcinolone Acetonide

C:intravitreal injection 16mg Triamcinolone Acetonid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: macular edema associated with Central Retinal Vein Occlusion; macular edema associated with Branch Retinal Vein Occlusion

Exclusion criteria

Exclusion criteria: a prior diagnosis of glaucoma, history of intraocular surgery, combined with other eye diseases, or combined with other eye treatment

Design outcomes

Primary

Measure	Time frame
introcular pressure, FFA, foveal thicknesss, visual acuity;	—

Countries

China

Contacts

Public ContactYong Wei

weiyongdoctor@163.com+86 13991274161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026